Parambir S. Dulai

Research interests

Publications

• Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity

  Nature Microbiology · 2022 · 10.1038/s41564-021-01050-3

• Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

  Gastroenterology · 2021 · 10.1053/j.gastro.2020.10.065

• Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses

  Science Immunology · 2020 · 10.1126/sciimmunol.abb4432

• Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease

  Alimentary Pharmacology & Therapeutics · 2020 · 10.1111/apt.15719

• Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group

  ˜The œLancet. Gastroenterology & hepatology · 2020 · 10.1016/s2468-1253(19)30366-8

• Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease: A Meta-Analysis of Population-Based Cohorts

  Clinical Gastroenterology and Hepatology · 2020 · 10.1016/j.cgh.2020.10.039

• Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis

  Gastroenterology · 2020 · 10.1053/j.gastro.2020.06.043

• First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis

  Clinical Gastroenterology and Hepatology · 2020 · 10.1016/j.cgh.2020.01.008

• Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

  Arthritis Care & Research · 2019 · 10.1002/acr.23875

• Should We Divide Crohn’s Disease Into Ileum-Dominant and Isolated Colonic Diseases?

  Clinical Gastroenterology and Hepatology · 2019 · 10.1016/j.cgh.2019.04.040

• Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis

  Clinical Gastroenterology and Hepatology · 2019 · 10.1016/j.cgh.2019.02.044

• Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

  Gastroenterology · 2018 · 10.1053/j.gastro.2018.05.039

• Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

  The American Journal of Gastroenterology · 2018 · 10.1038/s41395-018-0162-0

• Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

  Clinical Gastroenterology and Hepatology · 2017 · 10.1016/j.cgh.2017.06.016

• Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

  Cell Metabolism · 2017 · https://doi.org/10.1016/j.cmet.2017.04.001

• Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis

  Hepatology · 2017 · https://doi.org/10.1002/hep.29085

• Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes

  Nature Reviews Gastroenterology & Hepatology · 2016 · 10.1038/nrgastro.2016.181

• Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis

  Clinical Gastroenterology and Hepatology · 2016 · 10.1016/j.cgh.2016.11.025

• Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events

  JAMA · 2016 · https://doi.org/10.1001/jama.2016.7602

• The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium

  The American Journal of Gastroenterology · 2016 · 10.1038/ajg.2016.236

• MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice

  Journal of Hepatology · 2016 · 10.1016/j.jhep.2016.06.005

• Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management

  Cancer Prevention Research · 2016 · 10.1158/1940-6207.capr-16-0124

• Systematic review with meta‐analysis: faecal diversion for management of perianal Crohn's disease

  Alimentary Pharmacology & Therapeutics · 2015 · 10.1111/apt.13356

• Risks of Serious Infection or Lymphoma With Anti–Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review

  Clinical Gastroenterology and Hepatology · 2014 · 10.1016/j.cgh.2014.01.021

Current projects

No projects listed.